Pharmaceutics

This page contains key pharmaceutical news on drug recalls, FDA clearance, safety communications and research. In cardiology, key pharmaceutic agents include antiplatelet therapies, anticoagulants, hypertension drugs, and drugs for heart failure and arrhythmias.   

pills-384846_960_720.jpg

Many nonvalvular AFib patients skip DOAC therapy altogether

The study's authors hope their work can help with the development of new interventions that target this issue. 

October 25, 2021
Selfie Older

The exact effect of statin use on COVID-19 outcomes remains unclear

Researchers examined data from nearly 470,000 patients.

October 25, 2021
Same-day discharge after TAVR is safe for low-risk patients, leads to considerable cost savings

Half-dose DOAC improves outcomes after LAAO

The new-look anticoagulation strategy was associated with a significant reduction in adverse outcomes.

October 19, 2021
FDA Recall

FDA announces recall of 2 hypertension medications

The affected batches were distributed from October 2018 to December 2020. 

October 14, 2021
Even patients who were never hospitalized for COVID-19 face a heightened risk of cardiovascular issues. #longcovid

The pandemic's impact on statin prescriptions

The analysis, published in Circulation: Cardiovascular Quality and Outcomes, included more than 20,000 patient encounters.

September 24, 2021

Web-based resource helps consumers make key decisions about statin use

Researchers tracked data from 500 participants who completed a web-based evaluation in their home.

September 10, 2021
Continuous and high-adherent statin users had lower baseline arterial stiffness which also grew more slowly over time, a new JAMA Network Open study finds.

ASCVD events, death more likely when patients ignore statin recommendations

These findings have important clinical implications for ASCVD prevention.

September 1, 2021
USPSTF updates its stance on aspirin use to prevent CVD, sees no benefit for patients 60 or older.

Edoxaban comparable to VKAs for treating AFib after TAVR

Researchers shared their findings at ESC Congress 2021 and in the New England Journal of Medicine

August 31, 2021

Around the web

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Trimed Popup
Trimed Popup